Published in J Clin Pathol on October 01, 1997
Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol (2000) 2.34
Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer (1998) 1.64
Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol (1998) 1.62
Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol (2000) 1.62
Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol (1999) 1.20
Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol (1999) 1.09
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J Cancer (2009) 1.04
Overexpression and mislocalization of the chromosomal segregation protein separase in multiple human cancers. Clin Cancer Res (2009) 1.01
Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma. Neoplasia (2012) 1.01
Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagn Pathol (2014) 1.00
PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention. Genes Cancer (2010) 0.98
Retracted Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma. Clin Biochem (2012) 0.97
EGFR expression in advanced head and neck cutaneous squamous cell carcinoma. Head Neck (2011) 0.93
Observer performance in the use of digital and optical microscopy for the interpretation of tissue-based biomarkers. Anal Cell Pathol (Amst) (2014) 0.93
Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation. Histopathology (2010) 0.90
siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer. PLoS One (2011) 0.89
Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel. Clin Exp Metastasis (2013) 0.88
DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma. Int J Med Sci (2013) 0.88
Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer. Br J Cancer (1998) 0.87
Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer. Curr Cancer Drug Targets (2015) 0.86
Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma. Hum Pathol (2012) 0.86
Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker. Int J Parasitol (2010) 0.85
What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas? J Clin Pathol (2000) 0.84
Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. PLoS One (2016) 0.84
FGFR4 and TGF-β1 expression in hepatocellular carcinoma: correlation with clinicopathological features and prognosis. Int J Med Sci (2013) 0.82
Bacterial translocation and immunohistochemical measurement of gut immune function. J Clin Pathol (2001) 0.82
Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications. BMC Cancer (2013) 0.82
SlideToolkit: an assistive toolset for the histological quantification of whole slide images. PLoS One (2014) 0.79
Association of mitochondrial DNA 10398 polymorphism in invasive breast cancer in malay population of peninsular malaysia. Malays J Med Sci (2012) 0.79
Potential Beneficial Effects of Si-Wu-Tang on White Blood Cell Numbers and the Gastrointestinal Tract of γ-Ray Irradiated Mice. Int J Biomed Sci (2014) 0.78
Evaluation environment for digital and analog pathology: a platform for validation studies. J Med Imaging (Bellingham) (2014) 0.78
Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis. Am J Nucl Med Mol Imaging (2016) 0.77
Expression of COX-2 and HER-2/neu and estrogen and progesterone receptor in primary squamous cell carcinomas of the endometrium. J Cancer Res Clin Oncol (2004) 0.77
Role of glycosyltransferase PomGnT1 in glioblastoma progression. Neuro Oncol (2014) 0.76
Leptin receptor expression during the progression of endometrial carcinoma is correlated with estrogen and progesterone receptors. Arch Med Sci (2016) 0.75
p53 regulation by TRP2 is not pervasive in melanoma. PLoS One (2014) 0.75
LRP5 Signaling in Osteosarcomagenesis: a Cautionary Tale of Translation from Cell Lines to Tumors. Transl Oncol (2016) 0.75
Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer. Oncoimmunology (2016) 0.75
Markers of inflammation and fibrosis in the orbital fat/connective tissue of patients with Graves' orbitopathy: clinical implications. Mediators Inflamm (2014) 0.75
miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway. Oncogenesis (2017) 0.75
Doses Lactobacillus reuteri depend on adhesive ability to modulate the intestinal immune response and metabolism in mice challenged with lipopolysaccharide. Sci Rep (2016) 0.75
Expression of Leucine-rich Repeat-containing G-protein Coupled Receptor 5 and CD44: Potential Implications for Gastric Cancer Stem Cell Marker. J Cancer Prev (2016) 0.75
Lactobacillus rhamnosus GG modulates innate signaling pathway and cytokine responses to rotavirus vaccine in intestinal mononuclear cells of gnotobiotic pigs transplanted with human gut microbiota. BMC Microbiol (2016) 0.75
Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst (1996) 3.45
Optimizing sampling efficiency of stereological studies in biology: or 'do more less well!'. J Microsc (1981) 2.75
The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol (1988) 2.05
Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res (1995) 1.82
Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood (1997) 1.82
Reproducibility of subjective immunoscoring of steroid receptors in breast cancer. Anal Quant Cytol Histol (1996) 1.62
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol (1997) 1.54
Loss of p53-immunostaining intensity in breast cancer. J Natl Cancer Inst (1996) 1.53
Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Lancet (1989) 1.37
C-erbB-2 immunostaining: problems with interpretation. J Clin Pathol (1994) 1.06
Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry. Lab Invest (1990) 1.05
Quality control in immunocytochemistry: experiences with the oestrogen receptor assay. J Clin Pathol (1992) 1.00
Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Lab Invest (1991) 0.97
Retinoblastoma protein in human breast carcinoma: immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues. J Pathol (1996) 0.94
Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus. Anal Quant Cytol Histol (1997) 0.94
Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections. Refinement and multiobserver evaluation. Anal Quant Cytol Histol (1993) 0.91
Quantitation in immunohistochemistry. A research method or a diagnostic tool in surgical pathology? Pathologica (1995) 0.88
Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma. Mod Pathol (1996) 0.83
Primary care in the accident and emergency department: I. Prospective identification of patients. BMJ (1995) 10.08
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
Age, gender, socioeconomic, and ethnic differences in patients' assessments of primary health care. Qual Health Care (2001) 5.56
Self-similarity and clustering in the spatial distribution of species. Science (2000) 5.54
Practice size: impact on consultation length, workload, and patient assessment of care. Br J Gen Pract (2001) 5.06
Primary care in the accident and emergency department: II. Comparison of general practitioners and hospital doctors. BMJ (1995) 5.02
Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol (1998) 4.94
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res (2000) 4.66
Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect (2007) 4.55
Passage of viral membrane proteins through the Golgi complex. J Mol Biol (1981) 4.48
Serum screening for Down's syndrome: some women's experiences. BMJ (1993) 4.29
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 4.13
The General Practice Assessment Survey (GPAS): tests of data quality and measurement properties. Fam Pract (2000) 4.06
Guidelines on the management of common bile duct stones (CBDS). Gut (2008) 3.58
Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol (1996) 3.45
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study. J Clin Oncol (2000) 3.33
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J Clin Oncol (2002) 2.86
Genetic polymorphism across regions of the three open reading frames of "Norwalk-like viruses". Arch Virol (2000) 2.84
Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature (1995) 2.79
Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature (1981) 2.71
Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol (2000) 2.70
A 'pseudo-AIDS' syndrome following from fear of AIDS. Br J Psychiatry (1985) 2.69
Psychological support and counselling for patients with acquired immune deficiency syndrome (AIDS). Genitourin Med (1985) 2.59
[Second Opinion Consult Clinic for Surgical Oncology in the Daniel den Hoed Clinic: analysis of the first 245 patients]. Ned Tijdschr Geneeskd (1999) 2.56
The hemifusion intermediate and its conversion to complete fusion: regulation by membrane composition. Biophys J (1995) 2.55
HTLV-III: should testing ever be routine? Br Med J (Clin Res Ed) (1986) 2.51
Family history and perceived vulnerability to some common diseases: a study of young people and their parents. J Med Genet (1996) 2.49
Dental therapists. Br Dent J (1996) 2.46
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol (2005) 2.33
Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27
Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med (1985) 2.23
Protein B of soluble methane monooxygenase from Methylococcus capsulatus (Bath). A novel regulatory protein of enzyme activity. J Biol Chem (1985) 2.18
Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Aliment Pharmacol Ther (2014) 2.17
Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer (2008) 2.15
Jejunal manometry patterns in health, partial intestinal obstruction, and pseudoobstruction. Gastroenterology (1983) 2.14
Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. Int J Gynecol Cancer (2008) 2.12
Evaluation of a degenerate primer for the PCR detection of human caliciviruses. Arch Virol (1996) 2.11
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res (2000) 2.09
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc Natl Acad Sci U S A (1995) 2.08
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci (2000) 2.08
Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut (2001) 2.05
Prevalence of antibody to poliovirus in England and Wales 1984-6. Br Med J (Clin Res Ed) (1986) 2.01
Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. N Engl J Med (1990) 1.99
Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup. J Natl Cancer Inst (2000) 1.99
Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut (2003) 1.98
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol (1994) 1.97
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm. Br J Cancer (2011) 1.95
Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am J Pathol (1993) 1.94
E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy. Cell (2000) 1.86
Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol (2008) 1.86
Comparison of specific and random priming in the reverse transcriptase polymerase chain reaction for genotyping group A rotaviruses. J Virol Methods (1999) 1.81
Physician-induced demand for medical care. J Hum Resour (1978) 1.80
How do nurses working in hospital accident and emergency departments perceive local general practitioners? A study in six English hospitals. Arch Emerg Med (1991) 1.79
Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma. Lancet (1984) 1.77
Expression and self-assembly of Grimsby virus: antigenic distinction from Norwalk and Mexico viruses. Clin Diagn Lab Immunol (1999) 1.77
Representing infant feeding: content analysis of British media portrayals of bottle feeding and breast feeding. BMJ (2000) 1.76
Healthy eating, activity and obesity prevention: a qualitative study of parent and child perceptions in Australia. Health Promot Int (2005) 1.75
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
The clinical spectrum and treatment of Lyme disease. Yale J Biol Med (1985) 1.70
Distinct epidemiological patterns of Norwalk-like virus infection. J Med Virol (2000) 1.66
Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer (1998) 1.64
Molecular characterization of bovine enteric caliciviruses: a distinct third genogroup of noroviruses (Norwalk-like viruses) unlikely to be of risk to humans. J Virol (2003) 1.64
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Interactions between T helper cells and dendritic cells during the rat mixed lymphocyte reaction. J Exp Med (1985) 1.63
Diversity within the VP4 gene of rotavirus P[8] strains: implications for reverse transcription-PCR genotyping. J Clin Microbiol (2000) 1.63
Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. Endocrinology (1996) 1.61
Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer (2003) 1.61
A rat model of bone cancer pain. Pain (2002) 1.61
Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol (1998) 1.61
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument. Ann Oncol (2000) 1.60
Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology (1996) 1.59
Molecular epidemiology of outbreaks of gastroenteritis associated with small round-structured viruses in East Anglia, United Kingdom, during the 1996-1997 season. J Clin Microbiol (1999) 1.57
Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer (2009) 1.55
Transvaginal ultrasonographic detection of congenital anomalies in the first trimester. Am J Obstet Gynecol (1990) 1.55
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. J Natl Cancer Inst (2010) 1.55
Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma (1999) 1.55
Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients. Ann Oncol (2005) 1.54
Koch's or Crohn's--or something else? Int J Clin Pract (1997) 1.54
A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin) Clin Cancer Res (1999) 1.54
Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer (2010) 1.54
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene (2012) 1.54
Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. Health Technol Assess (2009) 1.54
EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer (2008) 1.53
Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost (2012) 1.52
The impact of housing status on health care utilization among persons with HIV disease. J Health Care Poor Underserved (1996) 1.50
Understanding the problem of inadequately staging early ovarian cancer. Eur J Cancer (2010) 1.50
How does tetanus toxin act? Neuroscience (1981) 1.50
Use of prescribed drugs among older people in Japan: association with not having a regular physician. J Am Geriatr Soc (1999) 1.49
Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg (1997) 1.48
Antibodies to components of neutrophil cytoplasm: a new diagnostic tool in patients with Wegener's granulomatosis and systemic vasculitis. Q J Med (1988) 1.47
FNR is a direct oxygen sensor having a biphasic response curve. FEBS Lett (1997) 1.46
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer. Eur J Cancer (1991) 1.44